Insider Transactions Reported by 11 Insiders of F-star Therapeutics, Inc.

Location
Cambridge, United Kingdom

There are no Buy or Sell transactions made by insiders since 14 Mar 2025

F-star Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Todd C. Brady Director 17 Jun 2022
Nessan Bermingham Director 08 Mar 2023
Pamela M. Klein Director 17 Jun 2022
Patrick Johan Hendrik Krol Director 04 Jun 2021
Louis Kayitalire Chief Medical Officer 08 Mar 2023
Neil Brewis Chief Scientific Officer 08 Mar 2023
David Arkowitz Director 17 Jun 2022
Edward Benz Jr. Director 08 Mar 2023
Geoffrey Race Director 08 Mar 2023
Eliot Forster PRESIDENT AND CEO, Director 08 Mar 2023
Darlene Deptula-Hicks Treasurer And Chief Financial Officer 08 Mar 2023

Recent Insider Transactions by Companies or Individuals for F-star Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Louis Kayitalire Common Stock Disposition pursuant to a tender of shares in a change of control transaction -53.9% -29,236 25,019 08 Mar 2023 Direct
Louis Kayitalire Common Stock Disposed to Issuer -100% -25,019 0 08 Mar 2023 Direct
Louis Kayitalire Stock Option (right to buy) Disposed to Issuer -100% -129,522 0 08 Mar 2023 Direct
Eliot Forster Common Stock Disposed to Issuer -100% -73,959 0 08 Mar 2023 Direct
Eliot Forster Common Stock Disposition pursuant to a tender of shares in a change of control transaction -82.4% -347,578 73,959 08 Mar 2023 Direct
Eliot Forster Stock Option (right to buy) Disposed to Issuer -100% -419,861 0 08 Mar 2023 Direct
Neil Brewis Common Stock Disposition pursuant to a tender of shares in a change of control transaction -91.8% -105,088 9,375 08 Mar 2023 Direct
Neil Brewis Common Stock Disposed to Issuer -100% -9,375 0 08 Mar 2023 Direct
Neil Brewis Stock Option (right to buy) Disposed to Issuer -100% -229,293 0 08 Mar 2023 Direct
Geoffrey Race Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -3,937 0 08 Mar 2023 Direct
Geoffrey Race Stock Option (right to buy) Disposed to Issuer -100% -40,000 0 08 Mar 2023 Direct
Edward Benz Jr. Common Stock Disposed to Issuer -100% -4,385 0 08 Mar 2023 Direct
Edward Benz Jr. Stock Option (right to buy) Disposed to Issuer -100% -43,937 0 08 Mar 2023 Direct
Pamela M. Klein Stock Option (right to buy) Disposed to Issuer -100% -40,000 0 08 Mar 2023 Direct
Todd C. Brady Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -15,004 0 08 Mar 2023 Direct
Todd C. Brady Stock Option (right to buy) Disposed to Issuer -100% -40,000 0 08 Mar 2023 Direct
Nessan Bermingham Common Stock Disposition pursuant to a tender of shares in a change of control transaction -93.9% -97,547 6,328 08 Mar 2023 Direct
Nessan Bermingham Common Stock Disposed to Issuer -100% -6,328 0 08 Mar 2023 Direct
Nessan Bermingham Stock Option (right to buy) Disposed to Issuer -100% -74,111 0 08 Mar 2023 Direct
David Arkowitz Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -8,386 0 08 Mar 2023 Direct
David Arkowitz Stock Option (right to buy) Disposed to Issuer -100% -40,000 0 08 Mar 2023 Direct
Darlene Deptula-Hicks Common Stock Disposed to Issuer -100% -25,539 0 08 Mar 2023 Direct
Darlene Deptula-Hicks Common Stock Disposition pursuant to a tender of shares in a change of control transaction -54.8% -30,898 25,539 08 Mar 2023 Direct
Darlene Deptula-Hicks Stock Option (right to buy) Disposed to Issuer -100% -139,045 0 08 Mar 2023 Direct
Geoffrey Race Common Stock Options Exercise 3,937 3,937 29 Jul 2022 Direct
Geoffrey Race Stock Option (right to buy) Options Exercise -50% -3,937 3,937 29 Jul 2022 Direct
Eliot Forster Common Stock Options Exercise 162.5% 260,977 421,537 29 Jul 2022 Direct
Eliot Forster Stock Option (right to buy) Options Exercise -100% -260,977 0 29 Jul 2022 Direct
Neil Brewis Common Stock Options Exercise 202.5% 76,619 114,463 29 Jul 2022 Direct
Neil Brewis Stock Option (right to buy) Options Exercise -100% -76,619 0 29 Jul 2022 Direct
Todd C. Brady Stock Option Award 20,000 20,000 17 Jun 2022 Direct
Geoffrey Race Stock Option Award 20,000 20,000 17 Jun 2022 Direct
Edward Benz Jr. Stock Option Award 20,000 20,000 17 Jun 2022 Direct
Pamela M. Klein Stock Option Award 20,000 20,000 17 Jun 2022 Direct
Nessan Bermingham Stock Option Award 20,000 20,000 17 Jun 2022 Direct
David Arkowitz Stock Option Award 20,000 20,000 17 Jun 2022 Direct
Eliot Forster Stock Option (right to buy) Award 126,909 126,909 31 Mar 2022 Direct
Louis Kayitalire Stock Option (right to buy) Award 35,719 35,719 31 Mar 2022 Direct
Neil Brewis Stock Option (right to buy) Award 132,469 132,469 31 Mar 2022 Direct
Darlene Deptula-Hicks Stock Option (right to buy) Award 24,902 24,902 31 Mar 2022 Direct
Louis Kayitalire Stock Option (right to buy) Award 53,634 53,634 09 Jan 2022 Direct
Neil Brewis Stock Option (right to buy) Award 74,263 74,263 09 Jan 2022 Direct
Eliot Forster Stock Option (right to buy) Award 165,028 165,028 09 Jan 2022 Direct
Darlene Deptula-Hicks Stock Option (right to buy) Award 59,823 59,823 09 Jan 2022 Direct
Louis Kayitalire Common Stock Sale -0.12% $437 $6.83 -64 54,255 02 Nov 2021 Direct
Louis Kayitalire Common Stock Sale -0.12% $462 $7.23 -64 54,319 04 Oct 2021 Direct
Louis Kayitalire Common Stock Sale -1.9% $8,885 $8.43 -1,054 54,383 02 Jul 2021 Direct
Patrick Johan Hendrik Krol Stock Option Award 20,000 20,000 04 Jun 2021 Direct
Pamela M. Klein Stock Option Award 20,000 20,000 04 Jun 2021 Direct
Todd C. Brady Stock Option Award 20,000 20,000 04 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.